Relative Efficacy of Repeat Course of Intravenous methyLprednisolone and Intramuscular ACTH in the Treatment of Acute Relapse of Multiple Sclerosis After Sub Response to Initial Course of Intravenous Methylprednisolone (RECLAIM): a Single Center Pilot Study

Trial Profile

Relative Efficacy of Repeat Course of Intravenous methyLprednisolone and Intramuscular ACTH in the Treatment of Acute Relapse of Multiple Sclerosis After Sub Response to Initial Course of Intravenous Methylprednisolone (RECLAIM): a Single Center Pilot Study

Discontinued
Phase of Trial: Phase II/III

Latest Information Update: 24 Mar 2016

At a glance

  • Drugs Corticotropin (Primary) ; Methylprednisolone
  • Indications Multiple sclerosis
  • Focus Therapeutic Use
  • Acronyms RECLAIM
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 06 Sep 2011 Planned end date changed from 1 Sep 2010 to 1 Jan 2011 as reported by ClinicalTrials.gov.
    • 06 Sep 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top